A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The Chinese People’s Liberation Army General Hospital Hospital of Traditional Chinese Medicine is committed to providing exceptional service through their multidisciplinary care and clinical research.
Beijing, China Clinical Trial Location
Chinese PLA General Hospital
Side Rd of W. 4th Ring Rd Middle, Haidian District,